USA FDA Approves New J&J HIV Drug

Posted: May 23rd, 2011 ˑ Filled under: News ˑ  Comments Closed

By Jennifer Corbett Dooren

Of DOW JONES NEWSWIRES

WASHINGTON (Dow Jones)–The U.S. Food and Drug Administration Friday approved a new HIV drug made by a unit of Johnson & Johnson. (JNJ).

The drug, Edurant, also known by its generic name rilpivirine, was approved for use in combination with other drugs in treating HIV patients who haven’t been previously treated with other drugs.

More at:  http://online.wsj.com/article/BT-CO-20110520-710146.html



Comments are closed.